FormBio Receives Nomination for The Medicine Maker's 2023 Innovation Awards

Written By Kathleen Otto

FormBio is honored to be nominated, alongside 11 other companies, for The Medicine Maker's 2023 Innovation Awards. The nomination recognizes FormBio's groundbreaking technology, FORMsight, which utilizes AI and machine learning to enable rapid and secure modeling of billions of potential construct candidates for cell and gene development.

Kathleen Otto
Previous

Island Pharmaceuticals Administers Second Cohort in ISLA-101 Single Ascending Dose Study
Next

BioNTX Announces 10th Annual iC³ Summit and Support of International Pharma Logistics Masterclass